Bactiguard Holding AB (publ)

Stockholm Stock Exchange BACTI-B.ST

Bactiguard Holding AB (publ) Dividend Per Share for the year ending December 31, 2023: USD -0.00

Bactiguard Holding AB (publ) Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
  • Bactiguard Holding AB (publ) Dividend Per Share for the year ending December 31, 2022 was USD -0.00, a 0.00% change year over year.
  • Bactiguard Holding AB (publ) Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a 0.00% change year over year.
  • Bactiguard Holding AB (publ) Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
  • Bactiguard Holding AB (publ) Dividend Per Share for the year ending December 31, 2019 was USD -0.00, a 0.00% change year over year.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: BACTI-B.ST

Bactiguard Holding AB (publ)

CEO Ms. Christine Lind
IPO Date June 19, 2014
Location Sweden
Headquarters Alfred Nobels Allé 150
Employees 163
Sector Consumers Staples
Industries
Description

Bactiguard Holding AB (publ), a medical device company, engages in the development and supply of infection prevention solutions in Sweden and internationally. Its infection prevention solutions reduce the risk of healthcare associated infections and the use of antibiotics. The company's products portfolio of urinary catheters, endotracheal tubes, and central venous catheters reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter and BIP Endotracheal Tube, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention. The company's products also include Bactiguard Wound Care and Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for acute, chronic, and infected wounds; surgical sutures comprise non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement used in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 12.37

-2.86%

MCAP.ST

MedCap AB (publ)

USD 36.10

-0.13%

BONEX.ST

Bonesupport Holding AB (publ)

USD 30.85

-1.29%

CEVI.ST

CellaVision AB (publ)

USD 19.20

-5.48%

CAMX.ST

Camurus AB (publ)

USD 52.33

-2.11%

StockViz Staff

February 4, 2025

Any question? Send us an email